France’s medical cannabis trial sparks market battle

Tensions are rising between European companies, Canadian firms and French producers as France prepares to allow imports of cannabis-based medical treatments on a trial basis later this year.

Connexion journalist

Published Tuesday 10 March 2020 - 08:43 Modified Tuesday 10 March 2020 - 08:43

Del på Facebook Del på Twitter Del på e-post

The trial is set to last two years from September, with more than 3,000 patients in France expected to be the first to receive the new drugs.

Drug safety agency ANSM confirmed that it would be open to authorising “foreign products”, and said that it had already “auditioned” seven companies last year.

Several Canadian companies are already seeking to enter the market, along with Dutch firm Bedrocan and British group Emmac Life Sciences.

Stay informed:
Sign up to our free weekly e-newsletter
Subscribe to access all our online articles and receive our printed monthly newspaper The Connexion at your home. News analysis, features and practical help for English-speakers in France

Del på Facebook Del på Twitter Del på e-post

french news drugs cannabis medecine

White storks make strong return in France via nest ‘platforms’ and clipped wings

The Ligue pour la Protection des Oiseaux shares the conservation challenges in saving these birds from extinction
Hosting scheme in south-west France lets newcomers sample lifestyle

Households in nine Dordogne communes volunteer under Mes Nouveaux Voisins scheme
French boulangeries demand right for staff to work on May 1 so they can open

Artisan bakery owners can work but employees cannot, while certain industrial bakeries are allowed to remain open with workers